Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 385 to 392 of 392 entries
Sorted by: Best Match Show Resources per page
Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure.

Cardiology

Tanaka N, Dan K, Maeda T, Ishihara H, Teramura M, Ichihashi K, Takahashi Y, Tsuzura D, Shinoda A, Fujii M, Okada H, Teramoto T.
PMID: 34348260
Cardiology. 2021;146(6):739-747. doi: 10.1159/000518732. Epub 2021 Aug 03.

INTRODUCTION: Previous trials showed that tolvaptan improves acute heart failure (HF). However, the optimal timing for administering tolvaptan to achieve the best outcome remains unclear. Therefore, the current study investigated the relationship between the timing of tolvaptan treatment initiation...

Cite
Tanaka N, Dan K, Maeda T, et al. Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure. Cardiology. 2021;146(6):739-747doi: 10.1159/000518732.
Tanaka, N., Dan, K., Maeda, T., Ishihara, H., Teramura, M., Ichihashi, K., Takahashi, Y., Tsuzura, D., Shinoda, A., Fujii, M., Okada, H., & Teramoto, T. (2021). Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure. Cardiology, 146(6), 739-747. https://doi.org/10.1159/000518732
Tanaka, Nobukiyo, et al. "Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure." Cardiology vol. 146,6 (2021): 739-747. doi: https://doi.org/10.1159/000518732
Tanaka N, Dan K, Maeda T, Ishihara H, Teramura M, Ichihashi K, Takahashi Y, Tsuzura D, Shinoda A, Fujii M, Okada H, Teramoto T. Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure. Cardiology. 2021;146(6):739-747. doi: 10.1159/000518732. Epub 2021 Aug 03. PMID: 34348260.
Copy Download .nbib Format: NLM
Reversible Fronto-occipitotemporal Signaling Complements Task Encoding and Switching under Ambiguous Cues.

Cerebral cortex (New York, N.Y. : 1991)

Tsumura K, Kosugi K, Hattori Y, Aoki R, Takeda M, Chikazoe J, Nakahara K, Jimura K.
PMID: 34519334
Cereb Cortex. 2021 Sep 14; doi: 10.1093/cercor/bhab324. Epub 2021 Sep 14.

Adaptation to changing environments involves the appropriate extraction of environmental information to achieve a behavioral goal. It remains unclear how behavioral flexibility is guided under situations where the relevant behavior is ambiguous. Using functional brain mapping of machine learning...

Cite
Tsumura K, Kosugi K, Hattori Y, et al. Reversible Fronto-occipitotemporal Signaling Complements Task Encoding and Switching under Ambiguous Cues. Cereb Cortex. 2021;doi: 10.1093/cercor/bhab324.
Tsumura, K., Kosugi, K., Hattori, Y., Aoki, R., Takeda, M., Chikazoe, J., Nakahara, K., & Jimura, K. (2021). Reversible Fronto-occipitotemporal Signaling Complements Task Encoding and Switching under Ambiguous Cues. Cerebral cortex (New York, N.Y. : 1991), . https://doi.org/10.1093/cercor/bhab324
Tsumura, Kaho, et al. "Reversible Fronto-occipitotemporal Signaling Complements Task Encoding and Switching under Ambiguous Cues." Cerebral cortex (New York, N.Y. : 1991) vol. (2021). doi: https://doi.org/10.1093/cercor/bhab324
Tsumura K, Kosugi K, Hattori Y, Aoki R, Takeda M, Chikazoe J, Nakahara K, Jimura K. Reversible Fronto-occipitotemporal Signaling Complements Task Encoding and Switching under Ambiguous Cues. Cereb Cortex. 2021 Sep 14; doi: 10.1093/cercor/bhab324. Epub 2021 Sep 14. PMID: 34519334.
Copy Download .nbib Format: NLM
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.

Frontiers in medicine

Nozaki Y, Hidaka T, Ri J, Itami T, Tomita D, Okada A, Ashida C, Ikeda F, Yamamoto A, Funahashi K, Kinoshita K, Matsubara T, Funauchi M, Matsumura I.
PMID: 33968956
Front Med (Lausanne). 2021 Apr 21;8:643459. doi: 10.3389/fmed.2021.643459. eCollection 2021.

No abstract available.

Cite
Nozaki Y, Hidaka T, Ri J, et al. Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis. Front Med (Lausanne). 2021;8:643459doi: 10.3389/fmed.2021.643459.
Nozaki, Y., Hidaka, T., Ri, J., Itami, T., Tomita, D., Okada, A., Ashida, C., Ikeda, F., Yamamoto, A., Funahashi, K., Kinoshita, K., Matsubara, T., Funauchi, M., & Matsumura, I. (2021). Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis. Frontiers in medicine, 8643459. https://doi.org/10.3389/fmed.2021.643459
Nozaki, Yuji, et al. "Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis." Frontiers in medicine vol. 8 (2021): 643459. doi: https://doi.org/10.3389/fmed.2021.643459
Nozaki Y, Hidaka T, Ri J, Itami T, Tomita D, Okada A, Ashida C, Ikeda F, Yamamoto A, Funahashi K, Kinoshita K, Matsubara T, Funauchi M, Matsumura I. Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis. Front Med (Lausanne). 2021 Apr 21;8:643459. doi: 10.3389/fmed.2021.643459. eCollection 2021. PMID: 33968956; PMCID: PMC8096982.
Copy Download .nbib Format: NLM
Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.

Journal of clinical immunology

Tanita K, Sakura F, Nambu R, Tsumura M, Imanaka Y, Ohnishi H, Kato Z, Pan J, Hoshino A, Suzuki K, Yasutomi M, Umetsu S, Okada C, Takagi M, Imai K, Ohara O, Muise AM, Okada S, Morio T, Kanegane H.
PMID: 33694042
J Clin Immunol. 2021 May;41(4):791-794. doi: 10.1007/s10875-021-01014-6.

No abstract available.

Cite
Tanita K, Sakura F, Nambu R, et al. Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3. J Clin Immunol. 2021;41(4):791-794doi: 10.1007/s10875-021-01014-6.
Tanita, K., Sakura, F., Nambu, R., Tsumura, M., Imanaka, Y., Ohnishi, H., Kato, Z., Pan, J., Hoshino, A., Suzuki, K., Yasutomi, M., Umetsu, S., Okada, C., Takagi, M., Imai, K., Ohara, O., Muise, A. M., Okada, S., Morio, T., & Kanegane, H. (2021). Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3. Journal of clinical immunology, 41(4), 791-794. https://doi.org/10.1007/s10875-021-01014-6
Tanita, Kay, et al. "Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3." Journal of clinical immunology vol. 41,4 (2021): 791-794. doi: https://doi.org/10.1007/s10875-021-01014-6
Tanita K, Sakura F, Nambu R, Tsumura M, Imanaka Y, Ohnishi H, Kato Z, Pan J, Hoshino A, Suzuki K, Yasutomi M, Umetsu S, Okada C, Takagi M, Imai K, Ohara O, Muise AM, Okada S, Morio T, Kanegane H. Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3. J Clin Immunol. 2021 May;41(4):791-794. doi: 10.1007/s10875-021-01014-6. PMID: 33694042.
Copy Download .nbib Format: NLM
A smartphone-controlled amperometric immunosensor for the detection of Pacific ciguatoxins in fish.

Food chemistry

Campàs M, Leonardo S, Oshiro N, Kuniyoshi K, Tsumuraya T, Hirama M, Diogène J.
PMID: 34891085
Food Chem. 2021 Dec 02;374:131687. doi: 10.1016/j.foodchem.2021.131687. Epub 2021 Dec 02.

Ciguatoxins (CTXs) are marine neurotoxins produced by microalgae of the genera Gambierdiscus and Fukuyoa. CTXs may reach humans through food webs and cause ciguatera fish poisoning (CFP). An immunosensor for the detection of Pacific CTXs in fish was developed...

Cite
Campàs M, Leonardo S, Oshiro N, et al. A smartphone-controlled amperometric immunosensor for the detection of Pacific ciguatoxins in fish. Food Chem. 2021;374:131687doi: 10.1016/j.foodchem.2021.131687.
Campàs, M., Leonardo, S., Oshiro, N., Kuniyoshi, K., Tsumuraya, T., Hirama, M., & Diogène, J. (2021). A smartphone-controlled amperometric immunosensor for the detection of Pacific ciguatoxins in fish. Food chemistry, 374131687. https://doi.org/10.1016/j.foodchem.2021.131687
Campàs, Mònica, et al. "A smartphone-controlled amperometric immunosensor for the detection of Pacific ciguatoxins in fish." Food chemistry vol. 374 (2021): 131687. doi: https://doi.org/10.1016/j.foodchem.2021.131687
Campàs M, Leonardo S, Oshiro N, Kuniyoshi K, Tsumuraya T, Hirama M, Diogène J. A smartphone-controlled amperometric immunosensor for the detection of Pacific ciguatoxins in fish. Food Chem. 2021 Dec 02;374:131687. doi: 10.1016/j.foodchem.2021.131687. Epub 2021 Dec 02. PMID: 34891085.
Copy Download .nbib Format: NLM
Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.

Cancers

Fujioka Y, Sugiyama D, Matsumura I, Minami Y, Miura M, Atsuta Y, Ohtake S, Kiyoi H, Miyazaki Y, Nishikawa H, Takahashi N.
PMID: 34885012
Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235904.

Treatment-free remission (TFR) has become a therapeutic goal in chronic myeloid leukemia (CML), and approximately half of the patients with chronic phase-CML (CML-CP) with deep molecular remission (DMR) by tyrosine-kinase inhibitors (TKIs) have achieved TFR. However, the mechanism of...

Cite
Fujioka Y, Sugiyama D, Matsumura I, et al. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235904.
Fujioka, Y., Sugiyama, D., Matsumura, I., Minami, Y., Miura, M., Atsuta, Y., Ohtake, S., Kiyoi, H., Miyazaki, Y., Nishikawa, H., & Takahashi, N. (2021). Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. Cancers, 13(23), . https://doi.org/10.3390/cancers13235904
Fujioka, Yuki, et al. "Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235904
Fujioka Y, Sugiyama D, Matsumura I, Minami Y, Miura M, Atsuta Y, Ohtake S, Kiyoi H, Miyazaki Y, Nishikawa H, Takahashi N. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235904. PMID: 34885012; PMCID: PMC8657169.
Copy Download .nbib Format: NLM
Cytopathic effects and local immune responses in repeated neoadjuvant HSV-.

Asian journal of urology

Yanagisawa N, Satoh T, Tabata KI, Tsumura H, Nasu Y, Watanabe M, Thompson TC, Okayasu I, Murakumo Y, Baba S, Iwamura M.
PMID: 34401335
Asian J Urol. 2021 Jul;8(3):280-288. doi: 10.1016/j.ajur.2020.06.004. Epub 2020 Jun 16.

OBJECTIVE: Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with METHODS: Four high-risk PCa patients who received HSV-RESULTS: ssDNA LI in GT increased, indicating apoptosis, as well as tumor-infiltrating lymphocytes and CD68-positive macrophages, compared...

Cite
Yanagisawa N, Satoh T, Tabata KI, et al. Cytopathic effects and local immune responses in repeated neoadjuvant HSV-. Asian J Urol. 2020;8(3):280-288doi: 10.1016/j.ajur.2020.06.004.
Yanagisawa, N., Satoh, T., Tabata, K. I., Tsumura, H., Nasu, Y., Watanabe, M., Thompson, T. C., Okayasu, I., Murakumo, Y., Baba, S., & Iwamura, M. (2021). Cytopathic effects and local immune responses in repeated neoadjuvant HSV-. Asian journal of urology, 8(3), 280-288. https://doi.org/10.1016/j.ajur.2020.06.004
Yanagisawa, Nobuyuki, et al. "Cytopathic effects and local immune responses in repeated neoadjuvant HSV-." Asian journal of urology vol. 8,3 (2021): 280-288. doi: https://doi.org/10.1016/j.ajur.2020.06.004
Yanagisawa N, Satoh T, Tabata KI, Tsumura H, Nasu Y, Watanabe M, Thompson TC, Okayasu I, Murakumo Y, Baba S, Iwamura M. Cytopathic effects and local immune responses in repeated neoadjuvant HSV-. Asian J Urol. 2021 Jul;8(3):280-288. doi: 10.1016/j.ajur.2020.06.004. Epub 2020 Jun 16. PMID: 34401335; PMCID: PMC8356062.
Copy Download .nbib Format: NLM
Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report.

CEN case reports

Morimoto N, Nagahama K, Tsuura Y, Terai A, Tanabe M, Otani M, Shioji S, Hirasawa S, Aki S, Aoyagi M, Tanaka H.
PMID: 34455551
CEN Case Rep. 2021 Aug 29; doi: 10.1007/s13730-021-00641-7. Epub 2021 Aug 29.

We report a case of membranous nephropathy (MN) in a patient with tuberculosis infection and lung adenocarcinoma. A 50-year-old Filipino woman underwent a renal biopsy for the evaluation of proteinuria and hematuria. Immunofluorescence analysis revealed positive staining of IgG...

Cite
Morimoto N, Nagahama K, Tsuura Y, et al. Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report. CEN Case Rep. 2021;doi: 10.1007/s13730-021-00641-7.
Morimoto, N., Nagahama, K., Tsuura, Y., Terai, A., Tanabe, M., Otani, M., Shioji, S., Hirasawa, S., Aki, S., Aoyagi, M., & Tanaka, H. (2021). Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report. CEN case reports, . https://doi.org/10.1007/s13730-021-00641-7
Morimoto, Nobuhisa, et al. "Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report." CEN case reports vol. (2021). doi: https://doi.org/10.1007/s13730-021-00641-7
Morimoto N, Nagahama K, Tsuura Y, Terai A, Tanabe M, Otani M, Shioji S, Hirasawa S, Aki S, Aoyagi M, Tanaka H. Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report. CEN Case Rep. 2021 Aug 29; doi: 10.1007/s13730-021-00641-7. Epub 2021 Aug 29. PMID: 34455551.
Copy Download .nbib Format: NLM
Showing 385 to 392 of 392 entries